Cosmetic Surgery Product Demand to Reach $2.6 Billion

US demand for cosmetic surgery products is expected to advance 7.4 percent annually to $2.6 billion in 2014, based on a return to growth in cosmetic procedures following two weak recessionary years.  Nearly 16 million cosmetic procedures are expected to be performed in 2014 as America’s obsession with youth continues and new non-invasive procedures are introduced.  These and other trends, including market share and product segmentation, are presented in Cosmetic Surgery Products, a new study from The Freedonia Group, Inc., a Cleveland-based industry market research firm.

Injectables will remain the largest and the fastest growing segment of cosmetic surgery products, with annual demand gains of 9.4 percent through 2014.  Products such as BOTOX COSMETIC (Allergan) have been essentially synonymous with the procedures since their introduction, and will continue to lead growth going forward.  The first direct competition to BOTOX emerged in 2009 with the Food and Drug Administration (FDA)’s approval of DYSPORT (Medicis Pharmaceutical), which will help to reshape the injectables market.  Additionally, fast growth in demand for newer product types -- such as calcium hydroxylapatite and polymethylmethacrylate microspheres -- will further add to gains.

Demand for equipment for cosmetic surgery procedures suffered significantly during the recession as demand fell for invasive surgical procedures such as liposuction.  Rising demand for laser-based procedures will help to improve equipment demand performance going forward, as will the 2010 introductions of the first non-invasive liposuction procedures, which will require all new equipment for any providers wishing to offer these services.

Demand for implants will continue to see healthy growth, although it will be below the overall average pace through 2014.  However, disparate performance expectations for breast implants compared to other body and facial implants skew the larger picture; silicone breast implants will see gains of 9.5 percent per year, while saline breast implants, and lip, chin and cheek implants will all see drops in demand. 

The Freedonia Group is a leading international business research company, founded in 1985, that publishes more than 100 industry research studies annually. This industry analysis provides an unbiased outlook and a reliable assessment of an industry and includes product segmentation and demand forecasts, industry trends, demand history, threats and opportunities, competitive strategies, market share determinations and company profiles.